Clinical Trial Update: Efficacy and Safety of SYN-010 in IBS-C [Phase 2]

View source ↗

Summary

Phase 2 trial update for SYN-010 in irritable bowel syndrome with constipation (IBS-C) has been terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• SYN-010

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Irritable Bowel Syndrome With Constipation | Phase 2 | Status: TERMINATED | Results posted: 2021-09-05